Jaclyn N. Highland

2015- University of Maryland at Baltimore, Baltimore, MD, United States 
Neuropharmacology, Neuropsychopharmacology, Behavioral Neuroscience
"Jaclyn Highland"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zanos P, Highland JN, Liu X, et al. (2019) (R)-ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anesthetic doses. British Journal of Pharmacology
Highland JN, Zanos P, Georgiou P, et al. (2019) Group II metabotropic glutamate receptor blockade promotes stress resilience in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Zanos P, Highland JN, Stewart BW, et al. (2019) ()-hydroxynorketamine exerts mGlu receptor-dependent antidepressant actions. Proceedings of the National Academy of Sciences of the United States of America
Zanos P, Moaddel R, Morris PJ, et al. (2018) Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. Pharmacological Reviews. 70: 621-660
Zanos P, Nelson ME, Highland JN, et al. (2017) A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice. Eneuro. 4
See more...